EPGL and Novartis to Enter Discussions

IRVINE, Calif., July 30, 2015 /PRNewswire/ -- EP Global Communications, Inc. (Public OTC: EPGL) announced today that Novartis /Alcon executives have recently contacted the Company about discussing EPGL's electronic contact lens technologies.  Discussions will begin as early as Monday, August 3, 2015.  Novartis CEO Joe Jimenez has been quoted as saying that the coming electronic contact lens market could be worth tens of billions of dollars over the next several years.  Novartis partnered with Google in 2014 to create "smart contact lenses" and has been very public about their desire to develop such contact lenses successfully. 

As previously disclosed EPGL owns 100% of certain patents pending and jointly owns certain patents pending with CooperVision, Inc.  EPGL also remains in negotiations with CooperVision, Inc. as well.  "The technology speaks for itself and we intend to license it to all of the top companies, unless someone secures exclusivity,"  said Michael Hayes.  "We expect to announce a deal in the near future with someone who is a leader in the ophthalmic or technology field.  We are just at the beginning stages of the coming 'Vision Revolution' and things are beginning to heat up," Hayes added.

In an effort to be more specific about EPGL developments to the investment community, on August 3, 2015, EPGL will announce an innovative accessory device technology which every electronic contact lens wearer in the future could potentially need to own. 

About EP Global Communications, Inc.

EP Global Communications, Inc. is an advanced technology research and development company for both medical devices and consumer electronics devices specializing in microelectronic mechanical systems (MEMS).

SOURCE EP Global Communications, Inc.

Related Links

http://www.epglmed.com